1,144 Views | 0 Downloads
Address correspondence to Mark J. Mulligan, The Hope Clinic of the Emory Vaccine Center, 603 Church Street, Decatur, GA 30030. Email: mark.mulligan@emory.edu.
Srilatha Edupuganti and Rachel B. Eidex contributed equally.
Harvey Lipman is deceased.
The authors wish to dedicate the manuscript in memory of Harvey Lipman, PhD, Centers for Disease Control and Prevention biostatistician and coinvestigator on this study, who passed away during manuscript preparation.
The authors thank the study volunteers for their time and commitment to this trial.
The other members of the YF-Ig Study Team are Bali Pulendran, Angela Caliendo, Joseph Miller, Kirk Easley, Seema Garg, Benton Lawson, and Paula M. Frew.
We wish to acknowledge the following members of the YFV Vaccine Study Team who assisted with the conduct of the study (Jane Skvarich, Susan Lalor, Kenya Kirkendoll, Zabrina Furlow, Mersiha Hotic, Renata Dennis, Alexis Daugherty, Mary Bower, Wendy Nesheim, Summer Nijem, Pat Anderson, Joseph Hilinski, Heather Coote, and Eileen Osinski) and John Connolly at the Luminex Core at Baylor Institute for Immunology Research.
D.T. was employed by the study sponsor, Sanofi Pasteur, at the time that the study was conducted. Seema Garg moved to Sanofi Pasteur after the study was completed. These statements are made in the interest of full disclosure and not because the authors consider their employment to be a conflict of interest.
This work was supported by a grant from Sanofi Pasteur.
This work was facilitated by the Center for AIDS Research (CFAR) at Emory University (P30 AI050409).
© The American Society of Tropical Medicine and Hygiene